PROK2 and androgen insensitivity syndrome: Therefore, rather than attributing a generalized “aggressor” or “defender” function to prokineticin 2, future mechanistic studies should focus on delineating its context-dependent signaling pathways and interactions with disease-specific immune networks in AIS.